期刊
ORGANIC LETTERS
卷 -, 期 -, 页码 -出版社
AMER CHEMICAL SOC
DOI: 10.1021/acs.orglett.2c03368
关键词
-
资金
- National Natural Science Foundation of China [92056201, 82003592]
- Guangdong Provincial Key Laboratory of Chiral Molecule and Drug Discovery [2019B030301005]
- Program for Guangdong Introducing Innovative and Entrepreneurial Teams [2016ZT06Y337]
- Zhujiang Talent Program Postdoctoral
This study reports a method for synthesizing N-(anthrancen-9-ylmethyl) isoserines using a catalyst and chiral phosphoric acid in a multicomponent reaction. The method is efficient, selective, and applicable to a wide range of substrates, making it suitable for synthesizing drug intermediates.
N-(Anthrancen-9-ylmethyl) isoserines are useful drug intermediates but short for efficient synthesis. We herein report the synthesis of N-(anthrancen-9-ylmethyl) isoserines via a Rh-2(Ph3COO)(3)(OAc) and chiral phosphoric acid (CPA) synergistically catalyzed multicomponent reaction (MCR) of N-alkyl imines, alcohols, and diazoesters. The method representing the first example of N-alkyl imines-involved MCR is featured by high atom-economy, high diastereo-and enantioselectivities, and broad substrate scope. DFT calculations on the mechanism of the MCR reveals that the hydrophobic interactions and pi-pi stackings between N-(anthrancen-9-ylmethyl) imines and Rh-2(Ph3COO)(3)(OAc)/CPA cocatalyst is essential to the reactivity and stereocontrol. The synthetic applications of the MCR products include the semisynthesis of paclitaxel, its alkyne-tagged derivative, and beta-lactam as an anticancer agent overcoming paclitaxel-resistance. We expect this work to shed light on the development of new N-alkyl imines-involved reactions and on the synthesis of drugs with isoserines as intermediates.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据